Search Results - "Keijsers, R"

Refine Results
  1. 1

    Effectiveness and safety of infliximab in cardiac Sarcoidosis by Bakker, A.L.M., Mathijssen, H., Azzahhafi, J., Swaans, M.J., Veltkamp, M., Keijsers, R.G.M., Akdim, F., Post, M.C., Grutters, J.C.

    Published in International journal of cardiology (01-05-2021)
    “…Immunosuppressive therapy in active cardiac sarcoidosis (CS) might prevent potential life-threatening complications. Infliximab (IFX) is a tumor necrosis…”
    Get full text
    Journal Article
  2. 2

    [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial by Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, Wim. J.G., Keijsers, R. G.

    “…Introduction Immune-mediated interstitial pneumonitis may be treated with anti-CD20 therapy after failure of conventional therapies. However, clinical response…”
    Get full text
    Journal Article
  3. 3

    The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis by Mathijssen, H., Tjoeng, T. W. H., Keijsers, R. G. M., Bakker, A. L. M., Akdim, F., van Es, H. W., van Beek, F. T., Veltkamp, M. V., Grutters, J. C., Post, M. C.

    Published in EJNMMI research (20-12-2021)
    “…Background Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as…”
    Get full text
    Journal Article
  4. 4

    Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? by van Hoeij, F. B., Keijsers, R. G. M., Loffeld, B. C. A. J., Dun, G., Stadhouders, P. H. G. M., Weusten, B. L. A. M.

    “…Purpose In patients undergoing 18 F-FDG PET/CT, incidental colonic focal lesions can be indicative of inflammatory, premalignant or malignant lesions. The…”
    Get full text
    Journal Article
  5. 5

    Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin by Keijsers, R.R.M.C., van der Velden, H.M.J., van Erp, P.E.J., de Boer-van Huizen, R.T., Joosten, I., Koenen, H.J.P.M., van de Kerkhof, P.C.M.

    Published in British journal of dermatology (1951) (01-06-2013)
    “…Summary Background  In the pathogenesis of psoriasis, proinflammatory T cells are strongly involved in the inflammatory process, where regulatory T‐cell (Treg)…”
    Get full text
    Journal Article
  6. 6

    The cellulose resource matrix by Keijsers, Edwin R.P., Yılmaz, Gülden, van Dam, Jan E.G.

    Published in Carbohydrate polymers (01-03-2013)
    “…► Cellulose resources were categorized and classified according technical parameters. ► Conversion processes were classified according processing parameters…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Cellular sources of IL-17 in psoriasis: a paradigm shift? by Keijsers, Romy R. M. C., Joosten, Irma, van Erp, Piet E. J, Koenen, Hans J. P. M., van de Kerkhof, Peter. C. M.

    Published in Experimental dermatology (01-11-2014)
    “…Psoriasis is a common chronic inflammatory skin disease that results from interplay between the immune system and the epithelium. In the light of very…”
    Get full text
    Journal Article
  8. 8

    Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review by Hendriks, A.G.M., Keijsers, R.R.M.C., de Jong, E.M.G.J., Seyger, M.M.B., van de Kerkhof, P.C.M.

    “…Background  Most psoriasis patients suffering from mild to moderate disease are treated with first‐line topical treatments, including corticosteroids, vitamin…”
    Get full text
    Journal Article
  9. 9

    Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET by Keijsers, R G, Grutters, J C, Thomeer, M, Du Bois, R M, Van Buul, M M, Lavalaye, J, Van Den Bosch, J M, Verzijlbergen, F J

    “…The aim of this study was to investigate sensitivity of 67Ga imaging and 18F-FDG PET for sarcoidosis activity and their inter observer variability. Thirty-four…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review by Hendriks, A.G.M., Keijsers, R.R.M.C., de Jong, E.M.G.J., Seyger, M.M.B., van de Kerkhof, P.C.M.

    “…Background  Despite the availability of newer topical treatments, classical topical treatments for chronic plaque psoriasis still have an important position…”
    Get full text
    Journal Article
  12. 12

    Cutaneous application of leukotriene B4 as an in vivo model of psoriasis-like skin inflammation: an immunohistological study by Hendriks, A G M, Keijsers, R R M C, Seyger, M M B, van de Kerkhof, P C M, van Erp, P E J

    Published in Skin pharmacology and physiology (2014)
    “…Research has revealed new insights into the pathogenesis of psoriasis, leading to new therapeutic options. So far the order of changes in the pathogenesis of…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Earlobe sarcoidosis by Vorselaars, A D M, Keijsers, R G M, Grutters, J C

    “…Infliximab, a TNF-alpha blocking agent, is an upcoming therapeutic option for cases of refractory sarcoidosis. In pulmonary sarcoidosis, changes imaged by…”
    Get full text
    Journal Article
  15. 15

    Cutaneous complication after BCG vaccination: Case report and review of the literature by Keijsers, Romy R. M. C., Bovenschen, H. Jorn, Seyger, Marieke M. B.

    Published in The Journal of dermatological treatment (01-12-2011)
    “…Abstract The bacille Calmette-Guérin (BCG) vaccination protects against tuberculosis (TB)-related meningitis and disseminated tuberculosis. While severe…”
    Get full text
    Journal Article
  16. 16

    In Vivo Induction of Cutaneous Inflammation Results in the Accumulation of Extracellular Trap-Forming Neutrophils Expressing RORγt and IL-17 by Keijsers, Romy R.M.C, Hendriks, Anke G.M., van Erp, Piet E.J., van Cranenbroek, Bram, van de Kerkhof, Peter C.M., Koenen, Hans J.P.M., Joosten, Irma

    Published in Journal of investigative dermatology (01-05-2014)
    “…Clinical trials successfully using antibodies targeting IL-17 in psoriasis support the importance of IL-17 in the pathophysiology of this disease. However,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment by Keijsers, Romy R. M. C., Joosten, Irma, Hendriks, Anke G. M., Koenen, Hans J. P. M, van Erp, Piet E. J, van de Kerkhof, Peter C. M.

    Published in Experimental dermatology (01-01-2015)
    “…Diminished suppressive capacity of regulatory T cells (Treg) has been demonstrated in blood and in lesional skin of psoriatic patients. Treatment with…”
    Get full text
    Journal Article
  20. 20